Explore our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts.

2022 Year in Review

Bullseye Chart: The Psychedelic Drug Development Pipeline

Bullseye Chart: The Psychedelic Drug Development Pipeline

To celebrate our 2022 Year in Review series, we decided to publish a new visualisation of our Psychedelic Drug Development Tracker data: a bullseye chart.

Part of our Year in Review series

Access a PDF version of the chart for a higher-resoluton copy and contact us at hello@psychedelicalpha.com with any questions.

Part of our Year in Review series

This content is part of our 2022 Year in Review, which looks back at the past year through commentary and analysis, interviews and guest contributions.

Receive New Sections in Your Inbox

To receive future sections of the Review in your inbox, join our newsletter…

Browse Other Sections of the Review

To explore our Year in Review, visit this webpage.


Join Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.

Monthly $20 Annually $200

Subscribe to our
free newsletter


By signing up, you agree to our privacy policy. You can unsubscribe at any time.

Learn More About

Group, team &
corporate plans


Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.